Concepedia

Cheng‐Yuan Peng

CP

Statistics

Publications

168

Citations

9.5K

H-Index

46

Active since

1994

Affiliations

China Medical University(Current)

China Medical University Hospital

National Taiwan University Hospital

Chang Gung University

Cheng‐Yuan Peng is an author at China Medical University specializing in viral hepatitis, antiviral therapy, and viral hepatitis treatment.

ORCID

Publications per year

1994–2025

168

Publications

168

Mitotic and G <sub>2</sub> Checkpoint Control: Regulation of 14-3-3 Protein Binding by Phosphorylation of Cdc25C on Serine-216

Cheng‐Yuan Peng, Paul R. Graves, Richard S. Thoma et al. · Science · 1997 · 1.3K citations

, , +17

SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma

Pierce K. H. Chow, Mihir Gandhi, Say‐Beng Tan et al. · Journal of Clinical Oncology · 2018 · 650 citations

, , +16

Elbasvir–Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy

Gregory J. Dore, Frederick L. Altice, Alain H. Litwin et al. · Annals of Internal Medicine · 2016 · 363 citations · Full text

, , +17

All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study

Michael Manns, S. Pol, Ira M. Jacobson et al. · The Lancet · 2014 · 343 citations

, , +13

Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation.

Min Xu, Kelly-Ann Sheppard, Cheng‐Yuan Peng et al. · Molecular and Cellular Biology · 1994 · 284 citations · Full text

, , +10

1–5 of 168